ICCVAM panel report
This article was originally published in The Rose Sheet
Executive Summary
National Toxicology Program Interagency Center on Evaluation of Alternative Toxicological Methods is requesting comments on a report by Interagency Coordinating Committee on the Validation of Alternative Methods scientific peer review panel regarding the 3T3 mouse fibroblast test and the normal human keratinocyte method, agency says in July 11 Federal Register notice. Report contains conclusions from May 23 meeting, including recommendation that the in vitro cytotoxicity test methods are sufficient for use in a weight-of-evidence approach to determine the starting dose for acute oral in vivo toxicity testing (1"The Rose Sheet" May 29, 2006, p. 8). Comments are due Aug. 25...
You may also be interested in...
ICCVAM Peer Review Meeting Evaluates Two In Vitro Cytotoxicity Tests
Two in vitro cytotoxicity test methods are sufficient for use in a weight-of-evidence approach to determine the starting dose for acute oral in vivo toxicity testing, a scientific peer review panel concluded by consensus during a meeting of the Interagency Coordinating Committee on the Validation of Alternative Methods in Bethesda, Md. May 23
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.